{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T06:48:32Z","timestamp":1769928512900,"version":"3.49.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.drugalcdep.2019.107638","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T18:39:51Z","timestamp":1572719991000},"page":"107638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Evaluation of dynorphin and kappa-opioid receptor level in the human blood lymphocytes and plasma: Possible role as a biomarker in severe opioid use disorder"],"prefix":"10.1016","volume":"205","author":[{"given":"Kourosh","family":"Shahkarami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3392-3640","authenticated-orcid":false,"given":"Nasim","family":"Vousooghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereshteh","family":"Golab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Mohsenzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parastoo","family":"Baharvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitra-Sadat","family":"Sadat-Shirazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Babhadi-Ashar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atena","family":"Shakeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0688-5378","authenticated-orcid":false,"given":"Mohammad Reza","family":"Zarrindast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.107638_bib0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1471-4159.2003.01507.x","article-title":"Distinct effects of methamphetamine and cocaine on preprodynorphin messenger RNA in rat striatal patch and matrix","volume":"84","author":"Adams","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0010","first-page":"8","article-title":"Methadone treatment of opiate addiction: a systematic review of comparative studies","volume":"14","author":"Ali","year":"2017","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0015","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/08039488.2016.1276624","article-title":"Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness","volume":"71","author":"Amidfar","year":"2017","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuroscience.2016.02.071","article-title":"CART peptide and opioid addiction: expression changes in male rat brain","volume":"325","author":"Bakhtazad","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1369-1600.2011.00366.x","article-title":"The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction","volume":"18","author":"Bazov","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0030","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1007\/s12035-017-0844-4","article-title":"Dynorphin and kappa-opioid receptor dysregulation in the dopaminergic reward system of human alcoholics","volume":"55","author":"Bazov","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000050719","article-title":"Are the Twelve Steps more acceptable to drug users than to drinkers? A comparison of experiences of and attitudes to Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) among 200 substance misusers attending inpatient detoxification","volume":"7","author":"Best","year":"2001","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2012.05.005","article-title":"\u03ba-opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction","volume":"35","author":"Butelman","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pnpbp.2013.10.016","article-title":"Dynorphin\/KOP and nociceptin\/NOP gene expression and epigenetic changes by cocaine in rat striatum and nucleus accumbens","volume":"49","author":"Caputi","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0050","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0006-3223(99)00117-1","article-title":"Neurotransmitter interactions in schizophrenia\u2014therapeutic implications","volume":"46","author":"Carlsson","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0055","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1530-0277.2010.01148.x","article-title":"Effect of chronic ethanol on enkephalin in the hypothalamus and extra-hypothalamic areas","volume":"34","author":"Chang","year":"2010","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1530-0277.2006.00312.x","article-title":"Effect of ethanol on hypothalamic opioid peptides, enkephalin, and dynorphin: relationship with circulating triglycerides","volume":"31","author":"Chang","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/1044-0305(94)85078-X","article-title":"Matrix-assisted laser desorption mass spectrometry of biotransformation products of dynorphin a in vitro","volume":"5","author":"Chou","year":"1994","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0070","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1006\/bbrc.1995.1597","article-title":"Expression of kappa opioid receptors in human and monkey lymphocytes","volume":"209","author":"Chuang","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0079-6123(08)61788-4","article-title":"Inactivation of neuropeptides","volume":"104","author":"Csuhai","year":"1995","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1369-1600.2011.00326.x","article-title":"Different alcohol exposures induce selective alterations on the expression of dynorphin and nociceptin systems related genes in rat brain","volume":"18","author":"D\u2019addario","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/syn.890180106","article-title":"Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs","volume":"18","author":"Daunais","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0169-328X(94)00246-B","article-title":"Cocaine binges differentially alter striatal preprodynorphin and zif\/268 mRNAs","volume":"29","author":"Daunais","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0095","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00001756-199305000-00020","article-title":"Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum","volume":"4","author":"Daunais","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0361-9230(95)00049-K","article-title":"Short-term cocaine self administration alters striatal gene expression","volume":"37","author":"Daunais","year":"1995","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tins.2015.02.001","article-title":"Epigenetic mechanisms of chronic pain","volume":"38","author":"Descalzi","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0110","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)24578-5","article-title":"Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats","volume":"244","author":"Di Chiara","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0115","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1046\/j.1460-9568.2003.02636.x","article-title":"Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration","volume":"17","author":"Fagergren","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuropharm.2007.06.009","article-title":"Brain levels of neuropeptides in human chronic methamphetamine users","volume":"53","author":"Frankel","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuropharm.2008.04.019","article-title":"Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users","volume":"55","author":"Frankel","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0130","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1523\/JNEUROSCI.22-15-06747.2002","article-title":"Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers","volume":"22","author":"Gardell","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/SPC.0000000000000127","article-title":"Could targeting epigenetic processes relieve chronic pain states? Curr","volume":"9","author":"Geranton","year":"2015","journal-title":"Opin. Support Palliat. Care"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0140","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-009-1730-1","article-title":"Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity","volume":"208","author":"Gieryk","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrg1635","article-title":"The genetics of addictions: uncovering the genes","volume":"6","author":"Goldman","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0306-4522(03)00488-3","article-title":"Local mu and delta opioid receptors regulate amphetamine-induced behavior and neuropeptide mRNA in the striatum","volume":"121","author":"Gonzalez-Nicolini","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejphar.2009.04.060","article-title":"Dopamine receptors in human peripheral blood lymphocytes: changes in mRNA expression in opioid addiction","volume":"615","author":"Goodarzi","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2005.12.041","article-title":"Regulation of psychostimulant-induced preprodynorphin, c-fos and zif\/268 messenger RNA expression in the rat dorsal striatum by mu opioid receptor blockade","volume":"532","author":"Horner","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0169-328X(92)90058-J","article-title":"Cocaine self-administration differentially alters mRNA expression of striatal peptides","volume":"13","author":"Hurd","year":"1992","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/syn.890130408","article-title":"Molecular alterations in the neostriatum of human cocaine addicts","volume":"13","author":"Hurd","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0175","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1073\/pnas.98.2.625","article-title":"A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes","volume":"98","author":"Ilani","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.irn.2017.08.001","article-title":"Dynorphin\/kappa opioid receptor signaling in preclinical models of alcohol, drug, and food addiction","volume":"136","author":"Karkhanis","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1254\/jphs.14R03CP","article-title":"Nicotine effects and the endogenous opioid system","volume":"125","author":"Kishioka","year":"2014","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0190","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.biopsych.2013.03.014","article-title":"The one-two punch of alcoholism: role of central amygdala dynorphins\/kappa-opioid receptors","volume":"75","author":"Kissler","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2008.06.012","article-title":"A role for brain stress systems in addiction","volume":"59","author":"Koob","year":"2008","journal-title":"Neuron."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0200","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrd897","article-title":"Pharmacotherapy of addictions","volume":"1","author":"Kreek","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0205","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1038\/tp.2013.72","article-title":"Upregulated dynorphin opioid peptides mediate alcohol-induced learning and memory impairment","volume":"3","author":"Kuzmin","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0210","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1081\/JA-200033202","article-title":"Genetics and drug use as a complex phenotype","volume":"39","author":"Lessov","year":"2004","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpain.2012.10.005","article-title":"Epigenetic regulation of opioid-induced hyperalgesia, dependence, and tolerance in mice","volume":"14","author":"Liang","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2217\/epi.14.75","article-title":"Epigenetic regulation of chronic pain","volume":"7","author":"Liang","year":"2015","journal-title":"Epigenomics."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0225","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0741-8329(00)00118-X","article-title":"Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain","volume":"22","author":"Lindholm","year":"2000","journal-title":"Alcohol."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2016.07.039","article-title":"Down-regulation of purinergic P2X7 receptor expression and intracellular calcium dysregulation in peripheral blood mononuclear cells of patients with amyotrophic lateral sclerosis","volume":"630","author":"Liu","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0235","first-page":"88","article-title":"Functional evidence of pain control by the immune system","volume":"521","author":"Machelska","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0240","first-page":"605","volume":"18","author":"Malafoglia","year":"2017","journal-title":"study protocol for a randomized controlled trial. Trials"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0169-328X(97)00338-0","article-title":"Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat","volume":"54","author":"Mathieu-kia","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0250","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1523\/JNEUROSCI.0062-05.2005","article-title":"Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area","volume":"25","author":"Mcclung","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0255","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1210\/en.2003-1287","article-title":"Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain","volume":"145","author":"Mousa","year":"2004","journal-title":"Endocrinology."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0260","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF00432213","article-title":"Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning","volume":"86","author":"Mucha","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0265","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0024-3205(86)90309-7","article-title":"Preference conditioning produced by opioid active and inactive isomers of levorphanol and morphine in rat","volume":"38","author":"Mucha","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0270","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1023\/A:1016211910107","article-title":"Metabolism of dynorphin A 1-13 in human blood and plasma","volume":"12","author":"Muller","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0275","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1212\/WNL.46.3.791","article-title":"Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson\u2019s disease","volume":"46","author":"Nagai","year":"1996","journal-title":"Neurology."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0280","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.tips.2004.02.005","article-title":"Historical review: molecular and cellular mechanisms of opiate and cocaine addiction","volume":"25","author":"Nestler","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0285","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3389\/fpsyt.2018.00742","article-title":"Management of opioid addiction with opioid substitution treatments: beyond methadone and buprenorphine","volume":"9","author":"Noble","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0290","first-page":"251","article-title":"Assay and biochemical characterization of a dynorphin converting enzyme in human cerebrospinal fluid","volume":"75","author":"Nyberg","year":"1986","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0295","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(95)00279-Y","article-title":"Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal","volume":"683","author":"Nylander","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0300","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF02245939","article-title":"The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats","volume":"118","author":"Nylander","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0305","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0304-4165(91)90096-Y","article-title":"Enkephalin hydrolysis by human serum biotinidase","volume":"1074","author":"Oizumi","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0310","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1592\/phco.28.12.1453","article-title":"Comparison of opioid requirements and analgesic response in opioidtolerant versus opioid-naive patients after total knee arthroplasty","volume":"28","author":"Patanwala","year":"2008","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0315","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0361-9230(01)00525-1","article-title":"Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders","volume":"55","author":"Peckys","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0320","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0325","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0330","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/mds.22742","article-title":"Dopaminergic system in peripheral blood mononuclear cells in Parkinson\u2019s disease","volume":"25","author":"Pontieri","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0335","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0306-4522(96)83012-0","article-title":"The effect of single and repeated morphine administration on the prodynorphin system activity in the nucleus accumbens and striatum of the rat","volume":"70","author":"Przewlocka","year":"1996","journal-title":"Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(97)00829-X","article-title":"Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens","volume":"238","author":"Przewlocka","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0345","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-8993(92)90896-H","article-title":"The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat","volume":"584","author":"Rattan","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0350","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0169-328X(96)00091-5","article-title":"Chronic intracerebroventricular cocaine differentially affects prodynorphin gene expression in rat hypothalamus and caudate-putamen","volume":"40","author":"Romualdi","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0355","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2010.04.017","article-title":"Expression of NMDA receptor subunits in human peripheral blood lymphocytes in opioid addiction","volume":"638","author":"Roozafzoon","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(99)00675-8","article-title":"Downregulation of kappa opioid receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral tegmentum and nucleus accumbens","volume":"275","author":"Rosin","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0365","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1213\/ANE.0000000000000292","article-title":"Prolonged opioid use after knee arthroscopy in military veterans","volume":"119","author":"Rozet","year":"2014","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0370","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1556\/2006.7.2018.35","article-title":"Expression of NMDA receptor subunits in human blood lymphocytes: a peripheral biomarker in online computer game addiction","volume":"7","author":"Sadat-Shirazi","year":"2018","journal-title":"J. Behav. Addict."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0375","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2018.09.043","article-title":"Alteration of dopamine receptors subtypes in the brain of opioid abusers: a postmortem study in Iran","volume":"687","author":"Sadat-Shirazi","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0380","first-page":"12","article-title":"Epigenetic regulation of spinal cord gene expression contributes to enhanced postoperative pain and analgesic tolerance subsequent to continuous opioid exposure","volume":"18","author":"Sahbaie","year":"2016","journal-title":"Mol. Pain"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0385","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fncel.2015.00187","article-title":"Downregulation of the endogenous opioid peptides in the dorsal striatum of human alcoholics","volume":"9","author":"Sarkisyan","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0390","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.brainresbull.2005.04.018","article-title":"Steady-dose and escalating-dose \"binge\" administration of cocaine alter expression of behavioral stereotypy and striatal preprodynorphin mRNA levels in rats","volume":"67","author":"Schlussman","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0395","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pharmthera.2009.05.006","article-title":"30 years of dynorphins\u2014 new insights on their functions in neuropsychiatric diseases","volume":"123","author":"Schwarzer","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0400","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejphar.2010.02.007","article-title":"Expression of NR3B but not NR2D subunit of NMDA receptor in human blood lymphocytes can serve as a suitable peripheral marker for opioid addiction studies","volume":"633","author":"Sedaghati","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0405","first-page":"563","article-title":"Differential effects of mu and kappa opioid systems on motivational processes","volume":"75","author":"Shippenberg","year":"1986","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0410","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","article-title":"Dynorphin and the pathophysiology of drug addiction","volume":"116","author":"Shippenberg","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0415","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0022-3565(25)22808-7","article-title":"Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism","volume":"250","author":"Sivam","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0420","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2008.12.002","article-title":"Alterations of prodynorphin gene expression in the rat mesocorticolimbic system during heroin self-administration","volume":"1255","author":"Solecki","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0425","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0169-328X(95)00319-N","article-title":"Regulation of kappa opioid receptor mRNA in the rat brain by \"binge\u2019 pattern cocaine administration and correlation with preprodynorphin mRNA","volume":"38","author":"Spangler","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0430","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0169-328X(93)90133-A","article-title":"\u2019Binge\u2019 cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen","volume":"19","author":"Spangler","year":"1993","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0435","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-328X(96)00249-5","article-title":"Prodynorphin, proenkephalin and kappa opioid receptor mRNA responses to acute \"binge\" cocaine","volume":"44","author":"Spangler","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0440","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2018.09.023","article-title":"Dynorphin\/kappa-opioid receptor control of dopamine dynamics: implications for negative affective states and psychiatric disorders","volume":"1713","author":"Tejeda","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0445","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00018-011-0844-x","article-title":"The dynorphin\/kappa-opioid receptor system and its role in psychiatric disorders","volume":"69","author":"Tejeda","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0450","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0022-3565(25)20727-3","article-title":"Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078 into the blood-brain barrier","volume":"251","author":"Terasaki","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0455","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0006-8993(95)00809-5","article-title":"Effects of chronic opiate and opioid antagonist treatment on striatal opioid peptides","volume":"698","author":"Trujillo","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0460","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0143-4179(97)90015-9","article-title":"Effects of single and repeated morphine administration on the prodynorphin, proenkephalin and dopamine D2 receptor gene expression in the mouse brain","volume":"31","author":"Turchan","year":"1997","journal-title":"Neuropeptides."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0465","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0306-4522(97)00639-8","article-title":"Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain","volume":"85","author":"Turchan","year":"1998","journal-title":"Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0470","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0143-4179(98)90029-4","article-title":"Penetration of dynorphin 1-13 across the blood-brain barrier","volume":"32","author":"Turner","year":"1998","journal-title":"Neuropeptides."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0475","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-328X(01)00178-4","article-title":"Kappa opioid receptor stimulation decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum","volume":"93","author":"Tzaferis","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0480","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1523\/JNEUROSCI.20-18-07074.2000","article-title":"Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance","volume":"20","author":"Vanderah","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0485","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1523\/JNEUROSCI.21-01-00279.2001","article-title":"Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance","volume":"21","author":"Vanderah","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0490","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.intimp.2009.02.010","article-title":"Expression of mu opioid receptor splice variants mRNA in human blood lymphocytes: a peripheral marker for opioid addiction studies","volume":"9","author":"Vousooghi","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0495","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00702-015-1408-2","article-title":"mRNA expression of dopamine receptors in peripheral blood lymphocytes of computer game addicts","volume":"122","author":"Vousooghi","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0500","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1527-3458.2003.tb00248.x","article-title":"A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist","volume":"9","author":"Wadenberg","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0505","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3565(24)29312-5","article-title":"Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans","volume":"299","author":"Walsh","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0510","first-page":"560","article-title":"Levels of immunoreactive dynorphin A1-13 during development of morphine dependence in rats","volume":"19","author":"Wan","year":"1998","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0515","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-2999(87)90506-1","article-title":"Differential effects of heroin on opioid levels in the rat brain","volume":"139","author":"Weissman","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0520","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1046\/j.1460-9568.2000.00147.x","article-title":"Running and cocaine both upregulate dynorphin mRNA in medial caudate putamen","volume":"12","author":"Werme","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0525","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0361-9230(01)00496-8","article-title":"Elevation of guinea pig brain preprodynorphin mRNA expression and hypothalamic-pituitary-adrenal axis activity by \"binge\" pattern cocaine administration","volume":"55","author":"Yuferov","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0530","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-004-2087-0","article-title":"Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors","volume":"179","author":"Zhang","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0535","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuropharm.2012.10.015","article-title":"Chronic escalating cocaine exposure, abstinence\/withdrawal, and chronic re-exposure: effects on striatal dopamine and opioid systems in C57BL\/6J mice","volume":"67","author":"Zhang","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0540","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clineuro.2017.04.012","article-title":"Increased expression of P2X7 receptor in peripheral blood mononuclear cells correlates with clinical severity and serum levels of Th17-related cytokines in patients with myasthenia gravis","volume":"157","author":"Zhang","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2005.11.042","article-title":"Contingency does not contribute to the effects of cocaine self-administration on prodynorphin and proenkephalin gene expression in the rat forebrain","volume":"1069","author":"Ziolkowska","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.107638_bib0550","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1155\/2005\/275318","article-title":"Over-expression of dopamine D2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers","volume":"21","author":"Zvara","year":"2005","journal-title":"Dis. Markers"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619304156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619304156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:07:13Z","timestamp":1759828033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619304156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":110,"alternative-id":["S0376871619304156"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107638","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of dynorphin and kappa-opioid receptor level in the human blood lymphocytes and plasma: Possible role as a biomarker in severe opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107638"}}